NAIP pseudogene 4 (NAIPP4)

NAIP pseudogene 4 (NAIPP4) is classified as a pseudogene with little or no evidence supporting its role as a protein-coding or functional therapeutic target. NAIPP4 is annotated as a processed pseudogene in humans, with no evidence that it encodes a functional protein or is involved in biological pathways or disease states[3][4][5]. Pseudogenes are genomic DNA sequences similar to normal genes but generally non-functional; they typically arise from gene duplication or retrotransposition. As such, NAIPP4 is not considered a therapeutic or diagnostic molecular target. NAIPP4 is listed in major gene databases (e.g., GeneCards, NCBI, BioGPS) as a pseudogene with no protein product, no interaction partners, and no direct disease associations[3][4][5]. Closely related genes like NAIP (NLR family apoptosis inhibitory protein) are functional and have well-defined roles in cell death regulation[1][2], but NAIPP4 does not share these attributes. There are no known drugs, mechanisms, or biomarker uses associated with NAIPP4[3][4][5]. NAIP pseudogene 4 (NAIPP4) is a non-functional pseudogene, not a protein-coding gene, and has no recognized therapeutic or diagnostic relevance. Thus, it is not a valid molecular target for drug discovery or other biomedical applications.

Other names

NAIPP4